Gender comparisons in cardiogenic shock during ST elevation myocardial infarction treated by primary percutaneous

Vijay Kunadian1, Weiliang Qiu, Bilal Bawamia

  • 1Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, United Kingdom. vijay.kunadian@newcastle.ac.uk

Insights

Cardiogenic shock (CS) following acute myocardial infarction (AMI) has reduced hospital mortality in the primary percutaneous coronary intervention (PPCI) era. Despite higher CS incidence in women, outcomes were similar, showing no gender difference in mortality.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Interventional Cardiology

Background:

  • Cardiogenic shock (CS) is a major cause of death in acute myocardial infarction (AMI) patients.
  • Historically, CS mortality rates were high (70-80%), but have decreased with advancements like early revascularization and mechanical support.
  • Previous research indicated a higher CS incidence in women post-AMI.

Purpose of the Study:

  • To evaluate hospital mortality outcomes in patients with CS undergoing primary percutaneous coronary intervention (PPCI).
  • To investigate potential gender differences in mortality among CS patients treated with PPCI.

Main Methods:

  • Prospective data collection from April 2008 to October 2011 at a UK tertiary cardiac center.
  • Analysis of 2,864 patients undergoing PPCI for AMI, with a focus on the 141 patients diagnosed with CS.
  • Comparison of mortality rates and demographic data between male and female CS patients.

Main Results:

  • The overall hospital mortality for CS patients undergoing PPCI was 35.5%.
  • A higher proportion of women (7.1%) presented with CS compared to men (4.0%) (p <0.001).
  • Female CS patients were older on average (69.9 years) than male CS patients (64.2 years), yet hospital mortality showed no significant gender difference (35% vs 35.8%, p >0.99).

Conclusions:

  • Contemporary PPCI strategies have led to reduced incidence and improved hospital mortality for CS complicating AMI.
  • Remarkably, despite presenting with higher incidence and at an older age, women with CS showed no mortality difference compared to men.
  • Further long-term follow-up studies are needed to confirm the sustained absence of gender disparity in CS outcomes.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...